Cholestane-3β, 5α, 6β-triol Suppresses Proliferation, Migration, and Invasion of Human Prostate Cancer Cells

作者: Ching-Yu Lin , Chieh Huo , Li-Kuo Kuo , Richard A. Hiipakka , Richard Baker Jones

DOI: 10.1371/JOURNAL.PONE.0065734

关键词: Growth inhibitionCancer researchLNCaPBiologyCancer cellCell cycleMolecular biologyTriolCell growthCell cultureApoptosisGeneral Biochemistry, Genetics and Molecular BiologyGeneral Agricultural and Biological SciencesGeneral Medicine

摘要: Oxysterols are oxidation products of cholesterol. Cholestane-3β, 5α, 6β-triol (abbreviated as triol) is one the most abundant and active oxysterols. Here, we report that triol exhibits anti-cancer activity against human prostate cancer cells. Treatment cells with dose-dependently suppressed proliferation LNCaP CDXR-3, DU-145, PC-3 reduced colony formation in soft agar. Oral administration at 20 mg/kg daily for three weeks significantly retarded growth xenografts nude mice. Flow cytometric analysis revealed treatment 10–40 µM caused G1 cell cycle arrest while TUNEL assay indicated 20–40 induced apoptosis all lines. Micro-Western Arrays traditional Western blotting methods resulted expression Akt1, phospho-Akt Ser473, Thr308, PDK1, c-Myc, Skp2 protein levels well accumulation inhibitor p27Kip. Triol also Akt1 xenografts. Overexpression partially rescued inhibition by triol. migration invasion PC-3, CDXR-3 The proteins associated epithelial-mesenchymal transition focal adhesion kinase were affected these increased E-cadherin but decreased N-cadherin, vimentin, Slug, FAK, phospho-FAK Ser722, Tyr861 levels. Confocal laser microscopy redistribution β-actin α-tubulin periphery DU-145 Our observations suggest may represent a promising therapeutic agent advanced metastatic cancer.

参考文章(66)
M E Kaighn, Y Ohnuki, K S Narayan, L W Jones, J F Lechner, Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investigative urology. ,vol. 17, pp. 16- 23 ,(1979)
Paul J. COFFER, Jing JIN, James R. WOODGETT, Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochemical Journal. ,vol. 335, pp. 1- 13 ,(1998) , 10.1042/BJ3350001
Chun-Chieh Liu, Jong-Ming Hsu, Li-Kuo Kuo, Chih-Pin Chuu, Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer Medical Hypotheses. ,vol. 80, pp. 617- 619 ,(2013) , 10.1016/J.MEHY.2013.02.003
Julie Dufour, Emilie Viennois, Hugues De Boussac, Silvère Baron, Jean-Marc Lobaccaro, Oxysterol receptors, AKT and prostate cancer. Current Opinion in Pharmacology. ,vol. 12, pp. 724- 728 ,(2012) , 10.1016/J.COPH.2012.06.012
Chih-pin Chuu, Rou-Yu Chen, Richard A. Hiipakka, John M. Kokontis, Karen V. Warner, Jialing Xiang, Shutsung Liao, The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells Biochemical and Biophysical Research Communications. ,vol. 357, pp. 341- 346 ,(2007) , 10.1016/J.BBRC.2007.03.116
Shinichi Sakamoto, Richard O. McCann, Rajiv Dhir, Natasha Kyprianou, Talin1 Promotes Tumor Invasion and Metastasis via Focal Adhesion Signaling and Anoikis Resistance Cancer Research. ,vol. 70, pp. 1885- 1895 ,(2010) , 10.1158/0008-5472.CAN-09-2833
Timothy Gilligan, Philip W Kantoff, Chemotherapy for prostate cancer Urology. ,vol. 60, pp. 94- 100 ,(2002) , 10.1016/S0090-4295(02)01583-2